(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.

The three biggest winners today are INTEROIL EXPL PROD, ESTORIL SOL N, and OCEANTEAM.

Financial Asset	Price	Change	Updated (EST)
INTEROIL EXPL PROD (IOX.OL)	8.90	16.79%	2024-06-24 12:40:36
ESTORIL SOL N (ESON.LS)	6.20	9.73%	2024-06-24 12:23:12
OCEANTEAM (OTS.OL)	1.00	9.68%	2024-06-24 12:41:48
ARGENX SE (ARGX.BR)	406.30	9.28%	2024-06-24 12:04:57
TEKNA HOLDING (TEKNA.OL)	5.44	8.37%	2024-06-24 12:43:55
BERGENBIO (BGBIO.OL)	11.18	6.32%	2024-06-24 12:25:06
REACH SUBSEA (REACH.OL)	8.42	6.31%	2024-06-24 12:42:35
CADELER (CADLR.OL)	67.80	6.1%	2024-06-24 12:25:28
UMICORE (UMI.BR)	15.03	5.92%	2024-06-24 12:21:50
AVENIR TELECOM (AVT.PA)	0.11	5.58%	2024-06-24 12:46:10

The three biggest losers today are EASE2PAY NV, MEDISTIM, and ADOCIA.

Financial Asset	Price	Change	Updated (EST)
EASE2PAY NV (EAS2P.AS)	0.61	-16.89%	2024-06-24 12:01:44
MEDISTIM (MEDI.OL)	177.00	-8.05%	2024-06-24 12:41:05
ADOCIA (ADOC.PA)	7.08	-7.21%	2024-06-24 12:45:00
ATOS (ATO.PA)	1.10	-6.35%	2024-06-24 12:46:02
BENFICA (SLBEN.LS)	3.15	-5.69%	2024-06-24 12:23:01
NYXOAH (NYXH.BR)	7.72	-5.12%	2024-06-24 12:20:53
HOFSETH BIOCARE (HBC.OL)	1.96	-4.17%	2024-06-24 12:40:27
NORBIT (NORBT.OL)	73.60	-3.92%	2024-06-24 12:41:25
BORR DRILLING (BORR.OL)	64.30	-3.74%	2024-06-24 12:25:16
GREENYARD (GREEN.BR)	6.20	-3.73%	2024-06-24 12:20:04

Winners today

1. INTEROIL EXPL PROD (IOX.OL)

16.79% Price Change

Interoil Exploration and Production ASA, together with its subsidiaries, operates as an upstream oil exploration and production company in Argentina and Colombia. It engages in the acquisition, exploration, development, and operation of oil and natural gas properties. The company's portfolio includes two producing concessions and two exploration concessions in Colombia; and one exploration and seven production concessions in Argentina. Interoil Exploration and Production ASA was incorporated in 2005 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with INTEROIL EXPL PROD jumping 16.79% to €8.90 on Monday while Oslo Børs Benchmark Index_GI rose 0.72% to €1,417.06.

Earnings Per Share

As for profitability, INTEROIL EXPL PROD has a trailing twelve months EPS of kr0.03.

PE Ratio

INTEROIL EXPL PROD has a trailing twelve months price to earnings ratio of 296.6. Meaning, the purchaser of the share is investing kr296.6 for every norwegian krone of annual earnings.

Revenue Growth

Year-on-year quarterly revenue growth grew by 206.4%, now sitting on 24.45M for the twelve trailing months.

Volume

Today’s last reported volume for INTEROIL EXPL PROD is 1032570 which is 156.35% above its average volume of 402789.

More news about INTEROIL EXPL PROD.

2. ESTORIL SOL N (ESON.LS)

9.73% Price Change

Estoril Sol, SGPS, S.A., together with its subsidiaries, engages in the gaming activities and real estate businesses in Portugal and internationally. It owns gaming casinos, including casino do Estoril, Casino Lisboa, and Casino da Póvoa. It is also involved in the online casino games and gambling business, as well as online sports betting activities. In addition, it owns a plot of land in Monte Estoril. Further, the company engages in tourism business. The company was incorporated in 1958 and is headquartered in Estoril, Portugal. Estoril Sol, SGPS, S.A. is a subsidiary of Finansol – Sociedade de Controlo, SGPS, S.A.

PSI ended the session with ESTORIL SOL N jumping 9.73% to €6.20 on Monday, after two successive sessions in a row of losses. PSI jumped 0.31% to €6,590.90, following the last session’s downward trend on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, ESTORIL SOL N has a trailing twelve months EPS of €0.47.

PE Ratio

ESTORIL SOL N has a trailing twelve months price to earnings ratio of 13.19. Meaning, the purchaser of the share is investing €13.19 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 25.72%.

More news about ESTORIL SOL N.

3. OCEANTEAM (OTS.OL)

9.68% Price Change

Oceanteam ASA does not have significant operations. Previously, it engaged in a subsea and offshore business. The company was formerly known as Oceanteam Shipping ASA and changed its name to Oceanteam ASA in December 2015. Oceanteam ASA was incorporated in 2005 and is headquartered in Baerum, Norway.

Oslo Børs Benchmark Index_GI ended the session with OCEANTEAM jumping 9.68% to €1.00 on Monday while Oslo Børs Benchmark Index_GI jumped 0.72% to €1,417.06.

Earnings Per Share

As for profitability, OCEANTEAM has a trailing twelve months EPS of kr-0.24.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -21.79%.

Volume

Today’s last reported volume for OCEANTEAM is 113547 which is 20.92% below its average volume of 143587.

More news about OCEANTEAM.

4. ARGENX SE (ARGX.BR)

9.28% Price Change

argenx SE, a biotechnology company, engages in the developing of various therapies for the treatment of autoimmune diseases in the United States, Japan, Europe, Middle East, Africa, and China. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, generalized myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, thyroid eye disease, bullous pemphigoid, myositis, primary sjögren's syndrome, post-covid postural orthostatic tachycardia syndrome, membranous nephropathy, lupus nephropathy, anca-associated vasculitis, and antibody mediated rejection; ENHANZE SC; Empasiprubart for multifocal motor neuropath, delayed graft function, and dermatomyositis; and ARGX-119 for congenital myasthenic syndrome and amyotrophic lateral sclerosis. The company is developing ARGX-213 targets FcRn; ARGX-121 and ARGX-220 targets immune system; ARGX-109 targets IL-6; ARGX-118 for inflammation; and ARGX-109, as well as cusatuzumab, ARGX-112, ARGX-114, and ARGX-115. It owns VYVGART; VYVGART HYTRULO; VYVDURA; ARGENX; ABDEG; NHANCE; SIMPLE ANTIBODY; and ARGENXMEDHUB. The company has strategic partnership with AbbVie S.À.R.L., Zai Lab Limited, and LEO Pharma A/S; and collaboration and license agreement with Genor Biopharma Co. Ltd, Université Catholique de Louvain, Sopartec S.A., NYU Langone Health, Leiden University Medical Center, AgomAb Therapeutics NV, Broteio Pharma B.V., VIB vzw, University of Texas, BioWa, Inc., and Shire International GmbH. It has collaboration agreement with Genmab A/S to discover, develop, and commercialize novel therapeutic antibodies with applications in immunology and oncology, as well as a strategic collaboration with IQVIA Holdings Inc. to provide safety systems and services. argenx SE was incorporated in 2008 and is based in Amsterdam, the Netherlands.

BEL 20 ended the session with ARGENX SE rising 9.28% to €406.30 on Monday, after two consecutive sessions in a row of gains. BEL 20 rose 1.96% to €3,970.37, after two successive sessions in a row of gains, on what was an all-around positive trend trading session today.

Earnings Per Share

As for profitability, ARGENX SE has a trailing twelve months EPS of €-5.32.

Volatility

ARGENX SE’s last week, last month’s, and last quarter’s current intraday variation average was 1.13%, 0.49%, and 1.45%.

ARGENX SE’s highest amplitude of average volatility was 1.46% (last week), 1.41% (last month), and 1.45% (last quarter).

More news about ARGENX SE.

5. TEKNA HOLDING (TEKNA.OL)

8.37% Price Change

Tekna Holding ASA engages in the development, manufacture, and sale of micron and nano powders, and plasma process solutions in North America, Europe, Asia, and internationally. The company offers spherical powders, such as titanium, nickel, and aluminum alloys, as well as tungsten and tantalum; and nanopowders, including nickel, silicon, and copper nanopowders, as well as boron nitride nanotubes for use in additive manufacturing, metal injection molding, thermal spray, and hot isostatic pressing. It serves aviation, aerospace, medical, mining and drilling, energy storage, and microelectronics industries. The company was founded in 1990 and is headquartered in Sherbrooke, Canada. Tekna Holding ASA is a subsidiary of Arendals Fossekompani ASA.

Oslo Børs Benchmark Index_GI ended the session with TEKNA HOLDING jumping 8.37% to €5.44 on Monday while Oslo Børs Benchmark Index_GI rose 0.72% to €1,417.06.

Earnings Per Share

As for profitability, TEKNA HOLDING has a trailing twelve months EPS of kr-1.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -38.02%.

Yearly Top and Bottom Value

TEKNA HOLDING’s stock is valued at kr5.44 at 22:40 EST, way below its 52-week high of kr11.25 and way higher than its 52-week low of kr4.40.

Revenue Growth

Year-on-year quarterly revenue growth declined by 8%, now sitting on 40.14M for the twelve trailing months.

Volume

Today’s last reported volume for TEKNA HOLDING is 2700 which is 94.1% below its average volume of 45770.

Moving Average

TEKNA HOLDING’s value is below its 50-day moving average of kr6.03 and way below its 200-day moving average of kr7.37.

More news about TEKNA HOLDING.

6. BERGENBIO (BGBIO.OL)

6.32% Price Change

BerGenBio ASA, a clinical-stage biopharmaceutical company, engages in the development of medicines to treat drug resistant, metastatic cancers, and respiratory diseases in Norway. The company's lead clinical asset is the Bemcentinib (BGB016), an inhibitor of AXL receptor tyrosine kinase (AXL), which is in phase 1b/2a clinical trial to treat non-small cell lung cancer; and (BGBC008), which is in phase 2 clinical trial to treat second-line non-small cell lung cancer (2L NSCLC). It develops Bemcentinib, which is in preclinical trial to treat acute respiratory distress syndrome; Tilvestamab (BGB149), anti-AXL monoclonal antibody, which in phase 1 clinical trial for the treatment of ovarian cancer; and Mipasetamab Uzoptirine, which is in Phase 1 clinical trial for the treatment of solid tumors. BerGenBio ASA was incorporated in 2007 and is based in Bergen, Norway.

Oslo Børs Benchmark Index_GI ended the session with BERGENBIO rising 6.32% to €11.18 on Monday while Oslo Børs Benchmark Index_GI jumped 0.72% to €1,417.06.

Earnings Per Share

As for profitability, BERGENBIO has a trailing twelve months EPS of kr67.

PE Ratio

BERGENBIO has a trailing twelve months price to earnings ratio of 0.17. Meaning, the purchaser of the share is investing kr0.17 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -179.58%.

More news about BERGENBIO.

7. REACH SUBSEA (REACH.OL)

6.31% Price Change

Reach Subsea ASA provides subsea services in Norway and internationally. It operates in two segments, Oil & Gas and Renewable/Other. The company offers inspection, maintenance, and repair services, such as structural inspections, WROV operation, SCM changeout, scale squeeze operations, water injection, ready for operation, subsea equipment maintenance, repair, commissioning, and boulder clearance; and construction support services, including seabed intervention, boulder clearance, touchdown monitoring, and pre-lay and post- lay survey, as well as vessel, remotely operated vehicles, personnel, survey, and on demand engineering. It also provides asset integrity/pipeline inspection, and engineering and project management services; reach remote services comprising survey, inspection, and IMR and seabed intervention; seabed survey services consisting of site surveys and geohazard investigation, pipeline inspection, seabed mapping, UXO, general, and route surveys; offshore cable; marine construction; and rig and mooring services. In addition, the company offers geophysical monitoring services, which include 4D gravity, seafloor subsidence monitoring, depth watch for seismic nodes, injection integrity monitoring, well drilling, and real time seismic monitoring services; and environmental monitoring services that comprise earthquake monitoring and prediction, C02 storage, and geothermal energy exploitation. It serves oil and gas, renewables, and utilities sectors. The company was formerly known as Transit Invest ASA and changed its name to Reach Subsea ASA in December 2012. The company was incorporated in 1909 and is headquartered in Haugesund, Norway.

Oslo Børs Benchmark Index_GI ended the session with REACH SUBSEA rising 6.31% to €8.42 on Monday, after two successive sessions in a row of gains. Oslo Børs Benchmark Index_GI rose 0.72% to €1,417.06, following the last session’s downward trend on what was a somewhat bullish trend exchanging session today.

Earnings Per Share

As for profitability, REACH SUBSEA has a trailing twelve months EPS of kr0.89.

PE Ratio

REACH SUBSEA has a trailing twelve months price to earnings ratio of 9.46. Meaning, the purchaser of the share is investing kr9.46 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 27.53%.

Sales Growth

REACH SUBSEA’s sales growth is 20% for the current quarter and negative 1.7% for the next.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, REACH SUBSEA’s stock is considered to be oversold (<=20).

Yearly Top and Bottom Value

REACH SUBSEA’s stock is valued at kr8.42 at 22:40 EST, higher than its 52-week high of kr7.96.

More news about REACH SUBSEA.

8. CADELER (CADLR.OL)

6.1% Price Change

Cadeler A/S operates as an offshore wind farm transportation and installation contractor in Denmark. It also provides wind farm construction, maintenance, decommissioning, and other tasks within the offshore industry, as well as marine and engineering services. The company owns and operates four offshore jack-up windfarm installation vessels. Cadeler A/S was incorporated in 2008 and is headquartered in Copenhagen, Denmark.

Oslo Børs Benchmark Index_GI ended the session with CADELER jumping 6.1% to €67.80 on Monday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI rose 0.72% to €1,417.06, following the last session’s downward trend on what was a somewhat up trend trading session today.

Earnings Per Share

As for profitability, CADELER has a trailing twelve months EPS of kr-0.12.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.21%.

Volume

Today’s last reported volume for CADELER is 612217 which is 11.06% below its average volume of 688393.

More news about CADELER.

9. UMICORE (UMI.BR)

5.92% Price Change

Umicore SA operates as a materials technology and recycling company in Belgium, rest of Europe, the Asia-Pacific, North America, South America, and Africa. It operates through Catalysis, Energy & Surface Technologies, and Recycling segments. The Catalysis segment provides automotive catalysts for gasoline, and diesel light and heavy-duty diesel applications, including on-road and non-road vehicles; stationary catalysis for industrial emissions control; and produces precious metals-based compounds and catalysts for use in the pharmaceutical and fine chemicals industries, as well as fuel cell applications. The Energy & Surface Technologies segment offers cobalt and specialty materials, rechargeable battery materials, and electro-optic materials, as well as metal deposition solutions, including precious metal-based electroplating and PVD coating. The Recycling segment treats waste streams containing precious and other specialty metals from a range of industrial residues and end-of-life materials. This segment also produces precious metals-based materials for glass production, electric, and electronic applications. The company was formerly known as Union Minière du Haut Katanga and changed its name to Umicore SA in 2001. Umicore SA was founded in 1805 and is headquartered in Brussels, Belgium.

BEL 20 ended the session with UMICORE jumping 5.92% to €15.03 on Monday while BEL 20 rose 1.96% to €3,970.37.

Earnings Per Share

As for profitability, UMICORE has a trailing twelve months EPS of €1.6.

PE Ratio

UMICORE has a trailing twelve months price to earnings ratio of 9.39. Meaning, the purchaser of the share is investing €9.39 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.38%.

Dividend Yield

According to Morningstar, Inc., the next dividend payment is on Apr 29, 2024, the estimated forward annual dividend rate is 1.1 and the estimated forward annual dividend yield is 7.75%.

Volume

Today’s last reported volume for UMICORE is 300987 which is 55.26% below its average volume of 672809.

Revenue Growth

Year-on-year quarterly revenue growth declined by 34.2%, now sitting on 18.28B for the twelve trailing months.

More news about UMICORE.

10. AVENIR TELECOM (AVT.PA)

5.58% Price Change

Avenir Telecom S.A. designs and distributes mobile phones and mobility accessories in Europe, the Middle East, Africa, Asia, Oceania, and the Americas. The company also provides chargers, cables, memory cards, and screen protectors. It offers its products under the Energizer brand. The company was incorporated in 1989 and is headquartered in Marseille, France.

CAC 40 ended the session with AVENIR TELECOM jumping 5.58% to €0.11 on Monday, following the last session’s downward trend. CAC 40 rose 1.03% to €7,706.89, following the last session’s downward trend on what was an all-around positive trend trading session today.

Earnings Per Share

As for profitability, AVENIR TELECOM has a trailing twelve months EPS of €-0.29.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, AVENIR TELECOM’s stock is considered to be overbought (>=80).

More news about AVENIR TELECOM.

Losers Today

1. EASE2PAY NV (EAS2P.AS)

-16.89% Price Change

Ease2pay N.V. provides online payment services and platforms in the Netherlands. The company operates payment transaction platform, which offers users services to order and pay in one action; and parking solutions. It also operates a platform that connects travelers with providers of parking and charging facilities on the road and water. The company was formerly known as DOCDATA N.V. and changed its name to Ease2pay N.V. in February 2018. Ease2pay N.V. is based in Rotterdam, the Netherlands.

AEX-Index ended the session with EASE2PAY NV falling 16.89% to €0.61 on Monday while AEX-Index jumped 0.13% to €926.40.

Earnings Per Share

As for profitability, EASE2PAY NV has a trailing twelve months EPS of €-0.06.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -18.14%.

Volume

Today’s last reported volume for EASE2PAY NV is 221450 which is 862.32% above its average volume of 23012.

Moving Average

EASE2PAY NV’s worth is above its 50-day moving average of €0.57 and higher than its 200-day moving average of €0.59.

More news about EASE2PAY NV.

2. MEDISTIM (MEDI.OL)

-8.05% Price Change

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Europe, Asia, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplant surgery; and imaging probes for intraoperative use. It also provides QuickFit TTFM probes, which is designed to hold the vessel and ensure precise measurements on various types of vessel grafts; Vascular TTFM probes for locking slide mechanism designed to secure the vessel while minimizing the manipulation of fragile or calcified vessels; and Doppler probes that are used to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, the company distributes and sells third party medical equipment. Medistim ASA was founded in 1984 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with MEDISTIM dropping 8.05% to €177.00 on Monday, after two successive sessions in a row of gains. Oslo Børs Benchmark Index_GI jumped 0.72% to €1,417.06, following the last session’s downward trend on what was a somewhat positive trend exchanging session today.

Earnings Per Share

As for profitability, MEDISTIM has a trailing twelve months EPS of kr5.6.

PE Ratio

MEDISTIM has a trailing twelve months price to earnings ratio of 31.61. Meaning, the purchaser of the share is investing kr31.61 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 24.73%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 3.5%, now sitting on 525.64M for the twelve trailing months.

Dividend Yield

As maintained by Morningstar, Inc., the next dividend payment is on Apr 25, 2024, the estimated forward annual dividend rate is 4.5 and the estimated forward annual dividend yield is 2.34%.

Moving Average

MEDISTIM’s value is below its 50-day moving average of kr183.48 and way below its 200-day moving average of kr199.49.

More news about MEDISTIM.

3. ADOCIA (ADOC.PA)

-7.21% Price Change

Adocia SA, a clinical-stage biotechnology company, researches and develops formulations of pre-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. Its proprietary BioChaperone technological platform provides molecular delivery of therapeutic proteins. The company's clinical product pipeline includes insulin formulations, such as BioChaperone Lispro U100 and U200, which are ultra-rapid formulations based on rapid insulin lispro; BioChaperone Combo, a combination of acting insulin glargine and rapid-acting insulin lispro; and BioChaperone LisPram, a combination of prandial insulin with pramlintide, as well as M1Pram, a combination of insulin M1 and pramlintide. Its preclinical pipeline includes products for the treatment of diabetes and obesity comprising AdoShell Islets, an implant containing islets of Langerhans; AdOral Sema, an oral delivery of semaglutide; and AdoGel Sema for the long-term delivery of therapeutic agents. The company has a strategic alliance with Tonghua Dongbao Pharmaceutical Co., Ltd. to develop and commercialize BioChaperone Lispro and BioChaperone Combo in China and other Asian and Middle Eastern territories. Adocia SA was incorporated in 2005 and is headquartered in Lyon, France.

CAC 40 ended the session with ADOCIA dropping 7.21% to €7.08 on Monday, after two sequential sessions in a row of gains. CAC 40 jumped 1.03% to €7,706.89, following the last session’s downward trend on what was an all-around positive trend exchanging session today.

Earnings Per Share

As for profitability, ADOCIA has a trailing twelve months EPS of €-1.9.

Revenue Growth

Year-on-year quarterly revenue growth declined by 62.6%, now sitting on 10.84M for the twelve trailing months.

More news about ADOCIA.

4. ATOS (ATO.PA)

-6.35% Price Change

Atos SE provides digital transformation solutions and services worldwide. It offers advanced computing solutions; analytics, artificial intelligence, and automation solutions; cloud solutions; customer journey analytics and digital customer experience; decarbonization solutions; digital consulting; digital workplace solutions; edge computing and Internet of things solutions; and modern applications and platforms. The company also provides advance detection and response, data protection and governance, digital workplace security, IoT and OT security, trusted digital identities, and cybersecurity solutions; and infrastructure and foundation services. It serves financial services and insurance, healthcare and life sciences, manufacturing, public sector and defense, resources and services, and telecommunication and media industries. The company was incorporated in 1982 and is headquartered in Bezons, France.

CAC 40 ended the session with ATOS dropping 6.35% to €1.10 on Monday, following the last session’s downward trend. CAC 40 rose 1.03% to €7,706.89, following the last session’s downward trend on what was an all-around up trend exchanging session today.

Earnings Per Share

As for profitability, ATOS has a trailing twelve months EPS of €-31.04.

More news about ATOS.

5. BENFICA (SLBEN.LS)

-5.69% Price Change

Sport Lisboa e Benfica – Futebol, SAD operates a sports club in Portugal. The company was founded in 1904 and is headquartered in Lisbon, Portugal. Sport Lisboa e Benfica – Futebol, SAD operates as a subsidiary of Sport Lisboa e Benfica SGPS SA.

PSI ended the session with BENFICA dropping 5.69% to €3.15 on Monday while PSI rose 0.31% to €6,590.90.

Earnings Per Share

As for profitability, BENFICA has a trailing twelve months EPS of €1.54.

PE Ratio

BENFICA has a trailing twelve months price to earnings ratio of 2.05. Meaning, the purchaser of the share is investing €2.05 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.79%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, BENFICA’s stock is considered to be oversold (<=20).

Volume

Today’s last reported volume for BENFICA is 346 which is 86.05% below its average volume of 2481.

More news about BENFICA.

6. NYXOAH (NYXH.BR)

-5.12% Price Change

Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company's lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

BEL 20 ended the session with NYXOAH falling 5.12% to €7.72 on Monday while BEL 20 jumped 1.96% to €3,970.37.

Earnings Per Share

As for profitability, NYXOAH has a trailing twelve months EPS of €-1.5.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -40.72%.

Yearly Top and Bottom Value

NYXOAH’s stock is valued at €7.72 at 22:40 EST, way below its 52-week high of €17.60 and way higher than its 52-week low of €3.79.

Growth Estimates Quarters

The company’s growth estimates for the current quarter is 6.7% and a drop 70.4% for the next.

More news about NYXOAH.

7. HOFSETH BIOCARE (HBC.OL)

-4.17% Price Change

Hofseth BioCare ASA operates as a consumer and pet health ingredient supplier and incubator in Norway, the United Kingdom, France, Belgium, Europe, Japan, Asia, and the United States. The company's products include OmeGo, a salmon oil, which offers the full spectrum of fatty acids and omegas found naturally in fresh whole salmon; ProGo, a bioactive peptide for VMS, metabolism, and active nutrition needs; CalGo, an absorbable complex mineral for bone and joint health; CollaGo; and PetGo, a non-soluble protein. The company was incorporated in 2000 and is headquartered in Ålesund, Norway.

Oslo Børs Benchmark Index_GI ended the session with HOFSETH BIOCARE dropping 4.17% to €1.96 on Monday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI rose 0.72% to €1,417.06, following the last session’s downward trend on what was a somewhat bullish trend trading session today.

Earnings Per Share

As for profitability, HOFSETH BIOCARE has a trailing twelve months EPS of kr-0.24.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -72.94%.

More news about HOFSETH BIOCARE.

8. NORBIT (NORBT.OL)

-3.92% Price Change

Norbit ASA provides technology products and solutions. It operates through Oceans, Connectivity, and Product Innovation and Realization segments. The company offers multibeam sonar systems, including integrated bathymetric systems, bathymetry systems, advanced monitoring systems for dredging, construction and renewables, forward looking wide area imaging, advanced imaging systems for obstacle avoidance/MCM, and above water laser products under the NORBIT WINGHEAD, NORBIT WBMS, NORBIT NORdredge, and NORBIT FLS names; customized cable assemblies, electromechanical box builds, and operational solutions; SeaCOP, a sensor integration platform and user interface common operational picture for emergency response; SECurus provides thermal and daylight stabilized camera solutions; SeaView, which offers thermal and daylight, pan, tilt, and zoom for environmental monitoring, and security and general surveillance; and SeaDarQ, a radar processing solution. It also provides sensing solutions for detecting threats at sea plus waterside security above and below the surface; FCL600, an underwater light solution for aquaculture industry; iData, which offers vehicle monitoring, telematics services, and fleet management for asset and vehicle management; and dedicated short-range communication technology for traffic system and vehicle application. In addition, the company offers research and development services, and contract manufacturing to industrial customers; and sells products based on proprietary technology, including special instrumentation n based on radar, radio frequency, and embedded signal processing technology. Norbit ASA was founded in 1995 and is headquartered in Trondheim, Norway.

Oslo Børs Benchmark Index_GI ended the session with NORBIT dropping 3.92% to €73.60 on Monday, after three sequential sessions in a row of gains. Oslo Børs Benchmark Index_GI jumped 0.72% to €1,417.06, following the last session’s downward trend on what was a somewhat positive trend exchanging session today.

Earnings Per Share

As for profitability, NORBIT has a trailing twelve months EPS of kr2.72.

PE Ratio

NORBIT has a trailing twelve months price to earnings ratio of 27.06. Meaning, the purchaser of the share is investing kr27.06 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 21.94%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 7.4%, now sitting on 1.55B for the twelve trailing months.

Dividend Yield

As claimed by Morningstar, Inc., the next dividend payment is on May 7, 2024, the estimated forward annual dividend rate is 2.55 and the estimated forward annual dividend yield is 3.47%.

Moving Average

NORBIT’s value is above its 50-day moving average of kr68.79 and way above its 200-day moving average of kr61.12.

More news about NORBIT.

9. BORR DRILLING (BORR.OL)

-3.74% Price Change

Borr Drilling Limited operates as an offshore shallow-water drilling contractor to the oil and gas industry worldwide. The company owns, contracts, and operates jack-up drilling rigs for operations in shallow-water areas, including the provision of related equipment and work crews to conduct oil and gas drilling and workover operations for exploration and production. It serves oil and gas exploration and production companies, such as integrated oil companies, state-owned national oil companies, and independent oil and gas companies. The company was formerly known as Magni Drilling Limited and changed its name to Borr Drilling Limited in December 2016. Borr Drilling Limited was incorporated in 2016 and is based in Hamilton, Bermuda.

Oslo Børs Benchmark Index_GI ended the session with BORR DRILLING sliding 3.74% to €64.30 on Monday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI rose 0.72% to €1,417.06, following the last session’s downward trend on what was a somewhat bullish trend exchanging session today.

Earnings Per Share

As for profitability, BORR DRILLING has a trailing twelve months EPS of kr1.9.

PE Ratio

BORR DRILLING has a trailing twelve months price to earnings ratio of 33.84. Meaning, the purchaser of the share is investing kr33.84 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -10.24%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 78.1%, now sitting on 616M for the twelve trailing months.

Volatility

BORR DRILLING’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.05%, a negative 0.22%, and a positive 2.20%.

BORR DRILLING’s highest amplitude of average volatility was 0.35% (last week), 1.45% (last month), and 2.20% (last quarter).

Volume

Today’s last reported volume for BORR DRILLING is 271348 which is 53.12% below its average volume of 578936.

More news about BORR DRILLING.

10. GREENYARD (GREEN.BR)

-3.73% Price Change

Greenyard NV, together with its subsidiaries, supplies fresh, frozen, and prepared fruit and vegetables, flowers, and plants in Germany, the Netherlands, Belgium, the United Kingdom, France, the rest of Europe, and internationally. The company operates through Fresh and Long Fresh segments. The Fresh segment markets and supplies fresh fruit and vegetables, flowers and plants, and fresh produce logistics. Its Long Fresh segment processes freshly harvested fruits and vegetables into frozen food products; and offers freshly preserved fruit, vegetables, and other ambient food products, as well as ready-made products, such as soups, sauces, dips, and pasta dishes. The company was formerly known as Greenyard Foods NV and changed its name to Greenyard NV in September 2016. Greenyard NV was founded in 1965 and is based in Sint-Katelijne-Waver, Belgium.

BEL 20 ended the session with GREENYARD falling 3.73% to €6.20 on Monday, after two sequential sessions in a row of losses. BEL 20 jumped 1.96% to €3,970.37, after two consecutive sessions in a row of gains, on what was an all-around up trend trading session today.

Earnings Per Share

As for profitability, GREENYARD has a trailing twelve months EPS of €0.16.

PE Ratio

GREENYARD has a trailing twelve months price to earnings ratio of 38.75. Meaning, the purchaser of the share is investing €38.75 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.12%.

Moving Average

GREENYARD’s worth is above its 50-day moving average of €5.64 and above its 200-day moving average of €5.67.

Dividend Yield

As stated by Morningstar, Inc., the next dividend payment is on Oct 3, 2023, the estimated forward annual dividend rate is 0.1 and the estimated forward annual dividend yield is 1.56%.

Yearly Top and Bottom Value

GREENYARD’s stock is valued at €6.20 at 22:40 EST, way under its 52-week high of €7.10 and way higher than its 52-week low of €5.00.

Volatility

GREENYARD’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.52%, a positive 0.29%, and a positive 1.48%.

GREENYARD’s highest amplitude of average volatility was 1.14% (last week), 1.41% (last month), and 1.48% (last quarter).

More news about GREENYARD.

Stay up to date with our winners and losers daily report